VirPath
Management
News - 2021
News - last quarter of 2020
News - third quarter of 2020
News - second quarter of 2020
News - first quarter of 2020
------------------------------
Integrative approach to influenza virus surveillance characterization and control
Collaborators
Publications
Thesis
------------------------------
Molecular and cellular signature of respiratory viruses, innovative antivirals and vaccines
Theme #1
Theme #2
Scientific production
Publications
Theses
Patents
Grants and funding
Collaborators
Partners
News - second half of 2019
News - first half of 2019
News 2018
News 2017
Fun
------------------------------
Virnext spin-off
VirHealth SAS
Signia Therapeutics
Vaxxel
------------------------------
Contact
Virology and human Pathology
VirPath
Management
News - 2021
News - last quarter of 2020
News - third quarter of 2020
News - second quarter of 2020
News - first quarter of 2020
------------------------------
Integrative approach to influenza virus surveillance characterization and control
------------------------------
Molecular and cellular signature of respiratory viruses, innovative antivirals and vaccines
Theme #1
Theme #2
Scientific production
Publications
Theses
Patents
Grants and funding
Collaborators
Partners
News - second half of 2019
News - first half of 2019
News 2018
News 2017
Fun
------------------------------
Virnext spin-off
VirHealth SAS
Signia Therapeutics
Vaxxel
------------------------------
Contact
Scientific production
Publications
Patents
Theses
Défiler vers le haut
fermer